Advertisement

Nasal and Lip Infantile Hemangiomas

  • Milton Waner
  • M. O Teresa
Chapter

Abstract

Infantile hemangiomas (IH, hemangiomas) of the nose comprise 15% of head and neck hemangiomas. Nasal hemangiomas are important because of their prominent location on the face and their liklihood to leave a disfiguring residuum after involution. Early treatment with propranolol is advocated and for those that fail to respond, surgical resection through a rim incision or a modified subunit approach is indicated. Lip hemangiomas are also common (20%) of all hemangiomas. Due to their prominent location, early treatment with propranolol is advocated and has been shown to improve the liklihood of a good outcome. Lesions greater than 2.83cm were associated with a poor outcome even with early propranolol treatment and surgical correction will be necessary.

Keywords

Hemangioma Infantile hemangioma Propranolol Ulceration PHACES Surgery nasal hemangiomas lip hemangiomas 

Notes

To assist the reader in gaining familiarity with available evidence, the following rating system has been used to indicate key references for each chapter’s content:

***: Critical material. Anyone dealing with this condition should be familiar with this reference.

**: Useful material. Important information that is valuable in in clinical or scientific practice related to this condition.

*: Optional material. For readers with a strong interest in the chapter content or a desire to study it in greater depth.

References

  1. 1.
    **Enjolras O. Classification and management of the various superficial vascular anomalies: hemangiomas and vascular malformations. J Dermatol. 1997;24(11):701–10.CrossRefGoogle Scholar
  2. 2.
    ***Waner M, North PE, Scherer KA, Frieden IJ, Waner A, Mihm MC Jr. The nonrandom distribution of facial hemangiomas. Arch Dermatol. 2003;139(7):869–75.CrossRefGoogle Scholar
  3. 3.
    van der Meulen JC, Gilbert M, Roddi R. Early excision of nasal hemangiomas: the L-approach. Plast Reconstr Surg. 1994;94(3):465–73; discussion 474–465.CrossRefGoogle Scholar
  4. 4.
    ***Waner M, Kastenbaum J, Scherer K. Hemangiomas of the nose: surgical management using a modified subunit approach. Arch Facial Plast Surg. 2008;10(5):329–34.CrossRefGoogle Scholar
  5. 5.
    ***Hamou C, Diner PA, Dalmonte P, et al. Nasal tip haemangiomas: guidelines for an early surgical approach. J Plast Reconstr Aesthet Surg. 2010;63(6):934–9.CrossRefGoogle Scholar
  6. 6.
    Arneja JS, Chim H, Drolet BA, Gosain AK. The Cyrano nose: refinements in surgical technique and treatment approach to hemangiomas of the nasal tip. Plast Reconstr Surg. 2010;126(4):1291–9.CrossRefGoogle Scholar
  7. 7.
    Ben-Amitai D, Halachmi S, Zvulunov A, Raveh E, Kalish E, Lapidoth M. Hemangiomas of the nasal tip treated with propranolol. Dermatology. 2012;225(4):371–5.CrossRefGoogle Scholar
  8. 8.
    **Perkins JA, Chen BS, Saltzman B, Manning SC, Parikh SR. Propranolol therapy for reducing the number of nasal infantile hemangioma invasive procedures. JAMA Otolaryngol Head Neck Surg. 2014;140(3):220–7.CrossRefGoogle Scholar
  9. 9.
    Sarkar R, Sethi S, Garg VK. Topical timolol in nasal tip hemangioma: a viable alternative to systemic therapy. Int J Dermatol. 2015;54(6):e239–41.CrossRefGoogle Scholar
  10. 10.
    Keller RG, Stevens S, Hochman M. Modern Management of Nasal Hemangiomas. JAMA Facial Plast Surg. 2017;19(4):327–32.CrossRefGoogle Scholar
  11. 11.
    Eivazi B, Cremer HJ, Mangold C, Teymoortash A, Wiegand S, Werner JA. Hemangiomas of the nasal tip: an approach to a therapeutic challenge. Int J Pediatr Otorhinolaryngol. 2011;75(3):368–75.CrossRefGoogle Scholar
  12. 12.
    ***Price CJ, Lattouf C, Baum B, et al. Propranolol vs corticosteroids for infantile hemangiomas: a multicenter retrospective analysis. Arch Dermatol. 2011;147(12):1371–6.CrossRefGoogle Scholar
  13. 13.
    ***Chinnadurai S, Sathe NA, Surawicz T. Laser treatment of infantile hemangioma: a systematic review. Lasers Surg Med. 2016;48(3):221–33.CrossRefGoogle Scholar
  14. 14.
    Burgos L, Lopez Gutierrez JC, Andres AM, et al. Early surgical treatment in nasal tip hemangiomas: 36 cases review. Cir Pediatr. 2007;20(2):83–6.PubMedGoogle Scholar
  15. 15.
    ***Costa VA, Haimowitz R, Cheng YI, Wang J, Silverman RA, Bauman NM. Social impact of facial infantile hemangiomas in preteen children. JAMA Otolaryngol Head Neck Surg. 2016;142(1):13–9.CrossRefGoogle Scholar
  16. 16.
    ***Yanes DA, Pearson GD, Witman PM. Infantile hemangiomas of the lip: patterns, outcomes, and implications. Pediatr Dermatol. 2016;33(5):511–7.CrossRefGoogle Scholar
  17. 17.
    ***O TM, Scheuermann-Poley C, Tan M, Waner M. Distribution, clinical characteristics, and surgical treatment of lip infantile hemangiomas. JAMA Facial Plast Surg. 2013;15(4):292–304.CrossRefGoogle Scholar
  18. 18.
    Chang CS, Wong A, Rohde CH, Ascherman JA, Wu JK. Management of lip hemangiomas: minimizing peri-oral scars. J Plast Reconstr Aesthet Surg. 2012;65(2):163–8.CrossRefGoogle Scholar
  19. 19.
    O TM, Alexander RE, Lando T, et al. Segmental hemangiomas of the upper airway. Laryngoscope. 2009;119(11):2242–7.CrossRefGoogle Scholar
  20. 20.
    ***Drolet BA, Frommelt PC, Chamlin SL, et al. Initiation and use of propranolol for infantile hemangioma: report of a consensus conference. Pediatrics. 2013;131(1):128–40.CrossRefGoogle Scholar
  21. 21.
    **Couto JA, Greene AK. Management of problematic infantile hemangioma using intralesional triamcinolone: efficacy and safety in 100 infants. J Plast Reconstr Aesthet Surg. 2014;67(11):1469–74.CrossRefGoogle Scholar
  22. 22.
    Grzesik P, Wu JK. Current perspectives on the optimal management of infantile hemangioma. Pediatr Health Med Ther. 2017;8:107–16.CrossRefGoogle Scholar
  23. 23.
    **Li WY, Chaudhry O, Reinisch JF. Guide to early surgical management of lip hemangiomas based on our experience of 214 cases. Plast Reconstr Surg. 2011;128(5):1117–24.CrossRefGoogle Scholar
  24. 24.
    *Cerrati EW, O TM, Chung H, Waner M. Diode laser for the treatment of telangiectasias following hemangioma involution. Otolaryngol Head Neck Surg. 2015;152(2):239–43.CrossRefGoogle Scholar
  25. 25.
    Couto RA, Maclellan RA, Zurakowski D, Greene AK. Infantile hemangioma: clinical assessment of the involuting phase and implications for management. Plast Reconstr Surg. 2012;130(3):619–24.CrossRefGoogle Scholar
  26. 26.
    Money S. The risks of chronic corticosteroid exposure. J Pain Palliat Care Pharmacother. 2017;31(2):160–1.CrossRefGoogle Scholar
  27. 27.
    *Poetke M, Philipp C, Berlien HP. Flashlamp-pumped pulsed dye laser for hemangiomas in infancy: treatment of superficial vs mixed hemangiomas. Arch Dermatol. 2000;136(5):628–32.CrossRefGoogle Scholar
  28. 28.
    Witman PM, Wagner AM, Scherer K, Waner M, Frieden IJ. Complications following pulsed dye laser treatment of superficial hemangiomas. Lasers Surg Med. 2006;38(2):116–23.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Milton Waner
    • 1
  • M. O Teresa
    • 2
  1. 1.Center for Vascular Anomalies, Center for Pediatric OtolaryngologyNew York Head & Neck InstituteNew YorkUSA
  2. 2.Vascular Birthmark Institute of New YorkManhattan Eye, Ear, and Throat and Lenox Hill HospitalsNew YorkUSA

Personalised recommendations